News Drug for ALS May Provide Benefit to Patients With Alzheimer’s In a pilot Phase 2 study, a drug was shown to slow brain metabolic decline and had a positive effect on cognitive performance versus placebo in people with mild Alzheimer’s disease.

Press/Media

Period29 Jul 2021

Media coverage

1

Media coverage